Abstract:Objectives Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT), a malignant inherited arrhythmias, is characterised by stress-induced bidirectional or polymorphic ventricular tachycardia in absence of structural cardiac abnormalities. Unexplained syncope or sudden death in young individuals may be ascribed to CPVT. Mutations of RyR2 gene were proved to cause autosomal dominant CPVT, while mutations of CASQ2 gene cause rare autosomal recessive CPVT. To date, 155 RyR2 mutations have been reported to cause CPVT, but no mutation is identified in mainland of China. We intend to study the variants and prevalence of RyR2 gene mutations in the Chinese CPVT patients. Methods The clinical characteristics of three CPVT families provided by the National Channellopathy Registry Study were investigated, including family and personal medical histories, 12-lead electrocardiography and 24-h ambulatory electrocardiography. DNA samples of the probands and their parents were extracted from serum leukocyte. 45 exons where the known mutation clusters located were first identified by direct DNA-sequencing of PCR-amplified DNA fragment. The primers used for PCR were designed with Primer3 or Oligo6 software. The remaining 60 exons would be identified if those results were negative. Results A novel heterozygous mutation was found in exon 8 at the 506th nucleotide (506G>A) on RyR2 in a 9-year old Chinese female child. This substitution resulted in an amino acid change from arginin to glutamin at the 169th position (R169Q). This mutation was absent in her parents and 50 control subjects (100 alleles) indicating that there is a de novo mutation occurred on the proband only. The first syncope occurred with bidirectional and polymorphic ventricular tachycardia recorded at the age of seven. A heart rate of 84 beats per minute and a QTc of 349 ms with right bundle branch block were observed. Despite the use of full-dose beta-blockade (metoprolol), stress-induced syncope re-occurred once a year during the following three years. Although radiofrequency current ablation was performed successfully at the age of eight, an unexpected sudden death still occurred at the age of 10. Exon 8 where R169 resides encodes thirty seven amino acids of the RyR2 N-terminal which are highly conserved among many species. Conclusions R169Q has been reported first in an 18-year-old Taiwanese woman by Hsueh in 2006. The present study identified R169Q on RyR2 gene again in a CPVT patient of China Mainland suggesting that this position might be a mutation hotspot in Chinese CPVT patients. The study laid foundation for further deepened study and specific management of this disease.

A novel RYR1 pathogenic variant − Common among Libyan Jews and associated with a broad phenotypic spectrum

Characterization of a Novel Mutation in the Cardiac Ryanodine Receptor That Results in Catecholaminergic Polymorphic Ventricular Tachycardia

Variant landscape of the RYR1 gene based on whole genome sequencing of the Singaporean population

RYR2 Mutations Are Associated With Benign Epilepsy of Childhood With Centrotemporal Spikes With or Without Arrhythmia

Case Report and Comparison with Additional Cases of Recessive RYR1-Related Myopathy

Novel RyR2 Mutation (G3118R) is Associated with Autosomal Recessive Ventricular Fibrillation and Sudden Death: Clinical, Functional, and Computational Analysis

Correlation of Phenotype–Genotype and Protein Structure in RYR1-Related Myopathy

Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature

Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study

One Case of Congenital Myopathy Caused by New Mutation of RYR1 Gene and Literature Review

Diverse Phenotypic Manifestations in a Family with a Novel RYR2 E4107A Variant

Structural changes and contractility in muscle assessed by magnetic resonance imaging in individuals with ryanodine receptor 1‐related rhabdomyolysis or myalgia

Rare Frameshift Variants Resulting in Protein Extension Cause Distal Myopathy and Hypertrophic Cardiomyopathy through Protein Aggregation

New evidence supports RYR3 as a candidate gene for developmental and epileptic encephalopathy

ARSA Variant Associated With Late Infantile Metachromatic Leukodystrophy and Carrier Rate in Individuals of Ashkenazi Jewish Ancestry

A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations

A Hotspot Mutation Ryr2-R169q for Chinese Patients with Catecholaminergic Polymorphic Ventricular Tachycardia

Identification of a Novel Frameshift Variant in MYF5 Leading to External Ophthalmoplegia with Rib and Vertebral Anomalies

Discovery of a Novel Shared Variant Among RTEL1 Gene and RTEL1-TNFRSF6B lncRNA at Chromosome 20q13.33 in Familial Progressive Myoclonus Epilepsy

Myoclonic epilepsy with ragged red fibers syndrome associated with mitochondrial 3302A>G mutation in the MT‑TL1 gene: A case report

A novel RyR2 mutation associated with co -morbid catecholaminergic polymorphic ventricular tachycardia (CPVT) and benign epilepsy with centrotemporal spikes (BECTS)